General Information of Drug (ID: DMOIC64)

Drug Name
6-Methyl-[1,3]dioxolo[4,5-h]quinolin-8(9H)-one
Synonyms 6-Methyl-[1,3]dioxolo[4,5-h]quinolin-8(9H)-one; 6-Methyl[1,3]dioxolo[4,5-H]quinolin-8(9h)-One; 1137557-67-5; casimiroin analogue, 1a; CHEMBL482693; BDBM29212
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 203.19
Logarithm of the Partition Coefficient (xlogp) 1.1
Rotatable Bond Count (rotbonds) 0
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 3
Chemical Identifiers
Formula
C11H9NO3
IUPAC Name
6-methyl-9H-[1,3]dioxolo[4,5-h]quinolin-8-one
Canonical SMILES
CC1=CC(=O)NC2=C1C=CC3=C2OCO3
InChI
InChI=1S/C11H9NO3/c1-6-4-9(13)12-10-7(6)2-3-8-11(10)15-5-14-8/h2-4H,5H2,1H3,(H,12,13)
InChIKey
XCKXJOHJSMHNFE-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
42618026
TTD ID
D0O4YS

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Quinone reductase 2 (NQO2) TTJLP0R NQO2_HUMAN Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Synthesis of casimiroin and optimization of its quinone reductase 2 and aromatase inhibitory activities. J Med Chem. 2009 Apr 9;52(7):1873-84.